HSE criticised for 'very unfair' underspend on new drug products

HSE criticised for 'very unfair' underspend on new drug products

Fianna Fáil MEP Billy Kelleher: 'The new minister for health must issue a directive to the HSE to ensure that new money for new medicines is spent on exactly that.' Picture: Sam Boal/RollingNews.ie

The HSE has been criticised for spending a third of its budget for new medicines on existing drugs in recent years.

Data from the HSE shows there was €98m earmarked for spending on new drug products for the health system between 2021 and 2023.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited